Hall 2 (Salle A, Floor 0)

08:00 - 09:00 BUSINESS MEETING
09:00 - 10:30

Innovations and the latest approach in managing ACHD patients with Heart Failure and Transplantation

Chair: Hannes Sallmon, Germany
Co-chair: Werner Budts, Belgium

Delivering patient centred care to adults with congenital heart disease and heart failure – what we can learn from the Covid 19 pandemic,
Louise Coats, UK
What can a global registry for outcomes in ACHD transplant deliver – introduction to Artoria R ,
Christopher Sinning, Germany
Delivering cavopulmonary support to the failing Fontan circulation -is the dream becoming a reality,
Peter Kramer, Germany
Determining the Optimal Transplant Listing Window for Patients with Fontan Physiology,
Clive Lewis, UK
Atrial flow Regulator (AFR) implantation in potential heart transplant recipients,
Nikolaus Haas, Germany

10:30 - 11:00 BREAK
11:30 - 12:30

Pulmonary Hypertension, Heart Failure and Transplantation
Chair: Julie Wacker, Switzerland
Co-chair: Colin McMahon, Ireland

O-043 Transcatheter creation of a restrictive atrial communication for treatment of patients with heart failure and hypertensive left atrial pressures,
Mustafa Gülgün, Germany
O-044 The preponderance of genetic involvement in paediatric pulmonary hypertension,
Julien Grynblat, France
O-045 Rimeporide, a first in class Na/H exchanger-1 inhibitor, ameliorates right ventricular dysfunction and pulmonary arterial hypertension in a SuHx model,
Giuseppina Milano, Switzerland
O-046 Validation of the New EPPVDN Pediatric Pulmonary Hypertension Risk Score by Cardiac Magnetic Resonance Imaging and Speckle Tracking Echocardiography,
Hosan Hasan, Germany
O-047 Long-Term Outcomes of Transcatheter Potts Shunt in Children with Suprasystemic Pulmonary Arterial Hypertension,
Raymond N. Haddad, France
O-048 Full recovery of right ventricular systolic function in children undergoing bilateral lung Transplantation for severe pulmonary arterial hypertension,
Georg Hansmann, Germany

14:00 - 15:30

Challenges in Paediatric Heart Transplantation

Chair: Maurice Beghetti, Switzerland
Co-chair: Taisto Sarkola, Finland

Rising to the challenge, this intervention can really delay transplant,
Milind Chaudhari, UK
Heart transplant rejection with haemodynamic compromise - treatment options,
Zdenka Reinhardt, UK
Integrating approaches for heart transplant rejection assessment. Is endomyocardial biopsy still necessary?,
Ina Michel-Behnke, Austria
Ideal post heart transplant shared care model,
Colin McMahon, Ireland

15:30 - 16:00 BREAK
16:00 - 17:30

Challenges in Paediatric Heart Failure in small children with cardiomyopathy Transplantation
Seperate / WG: Pulmonary Hypertension, Heart Failure and Transplantation
Chair: Zdenka Reinhardt, UK
Co-chair: Georg Hansmann, Germany

Disruption of sodium-dependent vitamin transport: a potential novel cause of cardiomyopathy,
Lauren Philips, UK
Precision medicine in cardiomyopathy,
Barbara Cardoso, UK
Debate: Pro Pro Medical Heart Failure Management of patient with DCM less than 5 kg,
Julie Wacker, Switzerland
Debate: Pro VAD support of patient with DCM less than 5 kg,
Oliver Miera, Germany